Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition

Journal of Immunology

Volumn 171, Issue 3, 2003, Pages 1376-1384

  Ishitani, Akiko ^a   Sageshima, Noriko ^a   Lee, Ni ^b   Dorofeeva, Natalia ^b   Hatake, Katsuhiko ^a   Marquardt, Hans ^c   Geraghty, Daniel E ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A;

AMINO ACID SEQUENCE; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PEPTIDE ANALYSIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING;

EID: 0041845075     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.3.1376     Document Type: Article

References (45)

1. Sargent, I. L. 1993. Maternal and fetal immune responses during pregnancy. Exp. Clin. Immunogenet. 10:85.
2. Le Bouteiller, P., A. M. Rodriguez, V. Mallet, M. Girr, T. Guillaudeux, and F. Lenfant. 1996. Placental expression of HLA class I genes. Am. J. Reprod. Immunol. 35:216.
3. Loke, Y. W., S. Hiby, and A. King. 1999. Human leucocyte antigen-G and reproduction. J. Reprod. Immunol. 43:235.
4. Geraghty, D. E., B. H. Koller, and H. T. Orr. 1987. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc. Natl. Acad. Sci. USA 84:9145.
5. Kovats, S., E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. DeMars. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220.
6. Ishitani, A., and D. E. Geraghty. 1992. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA 89:3947.
7. Fujii, T., A. Ishitani, and D. E. Geraghty. 1994. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153:5516.
8. Chu, W., M. E. Fant, D. E. Geraghty, and J. S. Hunt. 1998. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-γ-activated macrophages but not placental fibroblasts. Hum. Immunol. 59:435.
9. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951.
10. King, A., D. S. Allan, M. Bowen, S. J. Powis, S. Joseph, S. Verma, S. E. Hiby, A. J. McMichael, Y. W. Loke, and V. M. Braud. 2000. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30:1623.
11. Geraghty, D. E., X. H. Wei, H. T. Orr, and B. H. Koller. 1990. Human leukocyte antigen F (HLA-F): an expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J. Exp. Med. 171:1.
12. Lepin, E. J., J. M. Bastin, D. S. Allan, G. Roncador, V. M. Braud, D. Y. Mason, P. A. van der Merwe, A. J. McMichael, J. I. Bell, S. H. Powis, and C. A. O'Callaghan. 2000. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 30:3552.
13. Wainwright, S. D., P. A. Biro, and C. H. Holmes. 2000. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern. J. Immunol. 164:319.
14. Bainbridge, D., S. Ellis, P. Le Bouteiller, and I. Sargent. 2001. HLA-G remains a mystery. Trends Immunol. 22:548.
15. Lee, N., A. R. Malacko, A. Ishitani, M. C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591.
16. Diehl, M., C. Munz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H. G. Rammensee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6:305.
17. + cells by interacting with CD8. J. Immunol. 164:6100.
18. Sanders, S. K., P. A. Giblin, and P. Kavathas. 1991. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts. J. Exp. Med. 174:737.
19. Le Gal, F. A., B. Riteau, C. Sedlik, I. Khalil-Daher, C. Menier, J. Dausset, J. G. Guillet, E. D. Carosella, and N. Rouas-Freiss. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11:1351.
20. + T-lymphocytes. J. Reprod. Immunol. 48:17.
21. Allan, D. S., M. Colonna, L. L. Lanier, T. D. Churakova, J. S. Abrams, S. A. Ellis, A. J. McMichael, and V. M. Braud. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189:1149.
22. Chumbley, G., A. King, K. Robertson, N. Holmes, and Y. W. Loke. 1994. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol. 155:312.
23. Khalil-Daher, I., B. Riteau, C. Menier, C. Sedlik, P. Paul, J. Dausset, E. D. Carosella, and N. Rouas-Freiss. 1999. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J. Reprod. Immunol. 43:175.
24. Munz, C., N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H. G. Rammensee. 1997. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185:385.
25. Ponte, M., C. Cantoni, R. Biassoni, A. Tradori-Cappai, G. Bentivoglio, C. Vitale, S. Bertone, A. Moretta, L. Moretta, and M. C. Mingari. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96:5674.
26. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells [Published erratum appears in 2000 J. Exp. Med. 191:2027.] J. Exp. Med. 189:1093.
27. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199.
28. Llano, M., N. Lee, F. Navarro, P. Garcia, J. P. Albar, D. E. Geraghty, and M. Lopez-Botet. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28:2854.
29. Strong, R. K., M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty. 2003. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures and thermal stabilities. J. Biol. Chem. 278:5082.
30. Schatz, P. J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residues consensus pepfide specifies biotinylation in Escherichia coli. Biotechnology (NY) 11:1138.
31. Maresh, G. A., W. C. Wang, K. S. Beam, A. R. Malacko, I. Hellstrom, K. E. Hellstrom, and H. Marquardt. 1994. Differential processing and secretion of the melanoma-associated ME20 antigen. Arch. Biochem. Biophys. 311:95.
32. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85:227.
33. Pei, J., J. Rosielle, J. Hansen, and E. Mickelson. 2002. The IHWG cell and gene bank 2002: a comprehensive repository of reference reagents for analysis of the human MHC and immune regulator genes. Hum. Immunol. 63:S108.
34. Devergne, O., M. Hummel, H. Koeppen, M. M. Le Beau, E. C. Nathanson, E. Kieff, and M. Birkenbach. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:1143.
35. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185:1523.
36. Peruzzi, M., N. Wagtmann, and E. O. Long. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184:1585.
37. Samaridis, J., and M. Colonna. 1997. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27:660.
38. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
39. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class 1 molecules. J. Immunol. 160:3096.
40. Vales-Gomez, M., H. T. Reyburn, R. A. Erskine, M. Lopez-Botet, and J. L. Strominger. 1999. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:4250.
41. O'Callaghan, C. A., J. Tormo, B. E. Willcox, V. M. Braud, B. K. Jakobsen, D. I. Stuart, A. J. McMichael, J. I. Bell, and E. Y. Jones. 1998. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1:531.
42. Ober, C., C. Aldrich, B. Rosinsky, A. Robertson, M. A. Walker, S. Willadsen, M. S. Verp, D. E. Geraghty, and J. S. Hunt. 1998. HLA-G1 protein expression is not essential for fetal survival. Placenta 19:127.
43. Lopez-Botet, M., F. Navarro, and M. Llano. 1999. How do NK cells sense the expression of HLA-G class Ib molecules? Semin. Cancer Biol. 9:19.
44. Navarro, F., M. Llano, T. Bellon, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1999. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29:277.
45. O'Callaghan, C. A., and J. I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163:129.